PET-Based Thoracic Radiation Oncology.
Fluorodeoxyglucose-PET is increasingly being integrated into multiple aspects of oncology. PET/computed tomography (PET/CT) has become especially important in radiation oncology. With the increasing use of advanced techniques like intensity-modulated radiation therapy and proton therapy, PET/CT scans have played critical roles in the target delineation of tumors for radiation oncologists delivering conformal treatment techniques. Use of PET/CT is well established in lung cancer and several other thoracic malignancies. This article details the current uses of PET/CT in thoracic radiation oncology with a focus on lung cancer and describes expected future roles of PET/CT for thoracic tumors.
Department of Radiation Oncology, Hospital of the University of Pennsylvania, University of Pennsylvania, 3400 Civic Center Boulevard, TRC 2 West, Philadelphia, PA 19104, USA. Electronic address: charles.simone@uphs.upenn.edu.
Charles B
CB
Simone
Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Sina
S
Houshmand
Department of Radiation Oncology, Hospital of the University of Pennsylvania, University of Pennsylvania, 3400 Civic Center Boulevard, TRC 2 West, Philadelphia, PA 19104, USA.
Anusha
A
Kalbasi
Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA; Department of Radiology, University of Minnesota, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA.
Ali
A
Salavati
Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Abass
A
Alavi
D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*; D013899:Thoracic Neoplasms / Q000000981:diagnostic imaging*
Adaptive planning; Lung cancer; PET/CT; Personalized; Proton therapy; Radiation oncology; Stereotactic body radiation therapy; Target delineation